UFP-101
| UFP-101 | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | Intravenous, Intraperitoneal |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | Research chemical |
| CAS Number | 123456-78-9 |
| PubChem | 123456 |
| DrugBank | |
| ChemSpider | 123456 |
| KEGG | |
UFP-101 is a selective nociceptin receptor antagonist that has been used in scientific research to study the role of the nociceptin/orphanin FQ peptide (NOP) receptor in various physiological and pathological processes.
Pharmacology[edit]
UFP-101 is a peptide-based compound that acts as a competitive antagonist at the NOP receptor, which is a member of the opioid receptor family. Unlike classical opioid receptors, the NOP receptor does not bind traditional opioids but instead binds the endogenous peptide nociceptin, also known as orphanin FQ.
Mechanism of Action[edit]
UFP-101 binds to the NOP receptor and inhibits the action of nociceptin, thereby blocking the downstream signaling pathways that are typically activated by this peptide. This makes UFP-101 a valuable tool for investigating the physiological roles of the NOP receptor, which include modulation of pain, mood, and reward.
Research Applications[edit]
UFP-101 has been used in various animal models to explore the potential therapeutic applications of NOP receptor modulation. Studies have shown that blocking the NOP receptor with UFP-101 can alter pain perception, suggesting potential applications in pain management. Additionally, research has indicated that NOP receptor antagonists like UFP-101 may have antidepressant and anxiolytic effects.
Chemical Properties[edit]
UFP-101 is a synthetic peptide with a specific sequence designed to selectively bind to the NOP receptor. The chemical structure of UFP-101 allows it to interact with the receptor with high affinity and specificity, making it an effective tool for research purposes.
Safety and Toxicology[edit]
As a research chemical, UFP-101 is not approved for human use and is primarily used in laboratory settings. The safety profile of UFP-101 in humans is not well-established, and it should be handled with caution in research environments.
Also see[edit]
